Ειδήσεις: GILEAD SCIENCES | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

24/03 20:46 defenseworld.net

E. Ohman J or Asset Management AB Increases Stock Holdings in Gilead Sciences, Inc. $GILD

E. Ohman J Asset Management AB Gilead Sciences stock holdings biopharmaceutical

24/03 00:37 investing.com

Gilead to buy biotech firm Ouro Medicines in over $2 billion deal

Gilead Sciences Ouro Medicines acquisition biotech $2B oncology

23/03 18:42 investing.com

Gilead Sciences nears $2 billion Ouro Medicines acquisition - FT

Gilead Sciences Ouro Medicines acquisition oncology antibody‑drug conjugates precision medicine

20/03 09:16 defenseworld.net

AIA Group Ltd Increases Stock Position in Gilead Sciences, Inc. $GILD

AIA Group Gilead Sciences institutional investment 13F filing stock position Ameriprise

18/03 09:22 defenseworld.net

Gilead Sciences, Inc. $GILD Shares Purchased by Achmea Investment Management B.V.

Gilead Sciences Achmea Investment Management Q3 holdings biopharmaceutical SEC filing stock purchase

17/03 11:27 yahoo.com

Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and “long cycle” growth

Gilead Sciences CFO YEZTUGO Arcellx long‑cycle growth Barclays

17/03 10:14 defenseworld.net

Bank of Nova Scotia Sells 319,843 Shares of Gilead Sciences, Inc. $GILD

Bank of Nova Scotia Gilead Sciences hedge fund share sale institutional investor holdings

15/03 23:52 yahoo.com

Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades

Gilead Sciences analyst upgrades growth prospects drug pipeline revenue projections biotech stock

15/03 09:45 defenseworld.net

Ameriprise Financial Inc. Buys 400,002 Shares of Gilead Sciences, Inc. $GILD

Ameriprise Gilead Sciences institutional investment share purchase stake increase biopharma

15/03 09:45 defenseworld.net

Ameriprise Financial Inc. Buys 400,002 Shares of Gilead Sciences, Inc. $GILD

Ameriprise Gilead Sciences institutional investment share purchase stake increase biopharma

Loading...